Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Investment Summary

Market Valuation
Undervalued
Consensus
Skip
Best For

How This Company Makes Money

Dividend Snapshot ESPR

Max Ratio

Dividend Yield

99.37 %

5Y Dividend Growth

0.00 %

Consecutive Years

5Y Average Payout Ratio

Dividend History ESPR

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 99.37 %
Consecutive Years 0
Forward Annual Dividend 3.16 USD
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends 0
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date 07/13/2026

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Business Quality Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

MaxDividends Quality Score

Dividend Score

Sales Growth ESPR

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin ESPR

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income ESPR

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM ESPR

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio ESPR

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Esperion Therapeutics Inc ESPR

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Itself ESPR

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE
Forward PE 4.64
Enterprise Value Revenue 2.19
Price Sales TTM 1.96
Enterprise Value EBITDA 11.52
Price Book MRQ 98.42

Bottom Line

Esperion Therapeutics Inc

ESPR
Current price
3.18 USD 0 USD (0.00%)
Last closed 3.18 USD
ISIN US29664W1053
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 819 464 832 USD
Yield for 12 month +72.36 %
1Y
3Y
5Y
10Y
15Y
ESPR
11/21/2021 - 11/28/2021

Advanced Highlights

Current Year

+403 135 000 USD

Last Year

+332 314 000 USD

Current Quarter

+80 104 000 USD

Last Quarter

+168 446 000 USD

Current Year

+273 911 000 USD

Last Year

+263 713 000 USD

Current Quarter

+45 531 000 USD

Last Quarter

+140 592 000 USD
EBITDA 75 894 000 USD
Operating Margin TTM -8.22 %
Price to Earnings
Return On Assets TTM 12.04 %
PEG Ratio -4.78
Return On Equity TTM -260.79 %
Wall Street Target Price 3.20 USD
Revenue TTM 418 244 000 USD
Book Value -1.20 USD
Revenue Per Share TTM 1.89 USD
Dividend Share
Quarterly Revenue Growth YOY 23.20 %
Dividend Yield 99.37 %
Gross Profit TTM 241 702 000 USD
Earnings Per Share
Diluted EPS TTM
Most Recent Quarter I 2026
Quarterly Earnings Growth YOY
Profit Margin -1.78 %
Price to Free Cash Flow TTM -44.14

Technical Indicators ESPR

For 52 Weeks

1.74 USD 4.18 USD
50 Day MA 3.15 USD
Shares Short Prior Month 20 719 122
200 Day MA 3.09 USD
Short Ratio 1.58
Shares Short 17 401 689
Short Percent 6.87 %